Becton Dickinson Other Long-Term Assets 2010-2024 | BDX

Becton Dickinson other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Becton Dickinson other long-term assets for the quarter ending September 30, 2024 were $2.401B, a 16.61% increase year-over-year.
  • Becton Dickinson other long-term assets for 2023 were $2.078B, a 12.45% increase from 2022.
  • Becton Dickinson other long-term assets for 2022 were $1.848B, a 4.99% decline from 2021.
  • Becton Dickinson other long-term assets for 2021 were $1.945B, a 15.29% increase from 2020.
Becton Dickinson Annual Other Long-Term Assets
(Millions of US $)
2023 $2,078
2022 $1,848
2021 $1,945
2020 $1,687
2019 $1,088
2018 $1,078
2017 $1,007
2016 $824
2015 $717
2014 $488
2013 $487
2012 $500
2011 $445
2010 $488
2009 $465
Becton Dickinson Quarterly Other Long-Term Assets
(Millions of US $)
2024-06-30 $2,401
2024-03-31 $2,399
2023-12-31 $2,259
2023-09-30 $2,078
2023-06-30 $2,059
2023-03-31 $1,994
2022-12-31 $1,955
2022-09-30 $1,848
2022-06-30 $1,793
2022-03-31 $1,866
2021-12-31 $1,945
2021-09-30 $1,945
2021-06-30 $1,821
2021-03-31 $1,758
2020-12-31 $1,801
2020-09-30 $1,687
2020-06-30 $1,632
2020-03-31 $1,509
2019-12-31 $1,573
2019-09-30 $1,088
2019-06-30 $1,063
2019-03-31 $1,061
2018-12-31 $1,062
2018-09-30 $1,078
2018-06-30 $984
2018-03-31 $1,159
2017-12-31 $1,184
2017-09-30 $1,007
2017-06-30 $938
2017-03-31 $948
2016-12-31 $927
2016-09-30 $824
2016-06-30 $712
2016-03-31 $694
2015-12-31 $727
2015-09-30 $717
2015-06-30 $674
2015-03-31 $696
2014-12-31 $506
2014-09-30 $488
2014-06-30 $502
2014-03-31 $483
2013-12-31 $502
2013-09-30 $487
2013-06-30 $506
2013-03-31 $493
2012-12-31 $513
2012-09-30 $500
2012-06-30 $463
2012-03-31 $451
2011-12-31 $407
2011-09-30 $445
2011-06-30 $492
2011-03-31 $491
2010-12-31 $481
2010-09-30 $488
2010-06-30 $487
2010-03-31 $481
2009-12-31 $486
2009-09-30 $465
2009-06-30 $383
2009-03-31 $338
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $66.954B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Cardinal Health (CAH) United States $29.177B 15.82
West Pharmaceutical Services (WST) United States $23.472B 47.94
Cooper (COO) United States $20.662B 29.41
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
Merit Medical Systems (MMSI) United States $5.988B 30.58
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71